|

GLP-1 Hair Loss: Why It Happens, Whether It Grows Back & What May Help

Updated August 2026 | Mile High Peptides LLC Education Hub

Hair loss during GLP-1-assisted weight loss is getting increasing attention — and for good reason.

People researching semaglutide, tirzepatide, Ozempic®, Wegovy®, Mounjaro®, Zepbound®, and investigational compounds such as retatrutide frequently have the same questions:

Does a GLP-1 cause hair loss? Why does the shedding happen? Is it permanent? Will the hair grow back? And what can you do about it?

Newer research provides some answers.

A 2026 systematic review and meta-analysis involving 4,114 GLP-1 users found a significant association between GLP-1 receptor agonist use and hair loss. Another comprehensive 2026 review found the strongest hair-loss signals among semaglutide and tirzepatide and identified telogen effluvium and androgenetic alopecia as predominant types when the form of hair loss was specified.

However, that doesn’t mean researchers have proven that GLP-1 medications directly damage hair follicles.

Rapid weight loss, reduced calorie and protein intake, nutritional deficiencies, metabolic changes, and the physiological stress of substantial weight reduction may all contribute.

One particularly important explanation is telogen effluvium, a usually temporary, non-scarring form of excessive hair shedding.

And that’s important because with telogen effluvium, the hair follicle generally remains capable of growing hair again.

Here’s what current evidence tells us.

Quick Answer: Why Can Hair Fall Out While Using a GLP-1?

Hair shedding during GLP-1 treatment may result from several overlapping factors rather than one single cause.

Potential contributors include:

  • Rapid or substantial weight loss
  • Significant calorie restriction
  • Inadequate protein intake
  • Iron or other nutritional deficiencies
  • Physiological stress associated with major weight changes
  • Hormonal and metabolic changes
  • Telogen effluvium
  • Previously subtle genetic hair loss becoming more noticeable

Current research shows an association between certain GLP-1 therapies and hair loss, but researchers haven’t established that GLP-1 medications universally or directly damage human hair follicles.

Does GLP-1 Cause Hair Loss?

Research increasingly supports an association between GLP-1 receptor agonists and hair loss.

A 2026 systematic review and meta-analysis analyzed seven randomized controlled trials and two prospective nonrandomized studies involving 4,114 GLP-1 users.

Researchers found a significant association between GLP-1 receptor agonist use and hair loss, with semaglutide and tirzepatide among the drugs implicated.

A separate 2026 systematic review examining 24 studies similarly found that semaglutide and tirzepatide demonstrated the highest hair-loss incidence rates and more frequent signals in pharmacovigilance studies.

But an association isn’t the same thing as proving direct causation.

Researchers are still determining how much of the observed hair loss may result from:

  1. Medication effects
  2. Rapid weight loss
  3. Reduced calorie intake
  4. Inadequate protein or nutrient intake
  5. Hormonal or metabolic changes
  6. Underlying genetic hair loss
  7. A combination of these factors

This is why simply saying “GLP-1s make your hair fall out” doesn’t tell the whole story.

What Is Telogen Effluvium?

Telogen effluvium is a form of diffuse, non-scarring hair shedding that can occur after significant physiological stress.

To understand it, it helps to understand the normal hair-growth cycle.

Anagen — Growth

The follicle actively produces hair.

Catagen — Transition

Active growth slows as the follicle transitions.

Telogen — Resting

The hair remains within the follicle but is no longer actively growing.

Exogen — Shedding

The old hair is released as the follicle prepares for another growth cycle.

Most scalp hairs are normally in the growth phase.

A significant physiological stressor can cause more follicles than usual to transition away from active growth.

Potential triggers include:

  • Rapid weight loss
  • Significant calorie restriction
  • Nutritional deficiencies
  • Major illness
  • Surgery
  • Hormonal changes
  • Certain medications
  • Other major physical or psychological stressors

The affected hairs don’t necessarily fall out immediately.

They transition through their normal cycle first.

That’s why the shedding can appear long after the original trigger.

Why Does GLP-1 Hair Loss Start Months Later?

This delayed response is one of the most confusing aspects of telogen effluvium.

Hair shedding commonly becomes noticeable weeks to months after the triggering event, often around two to three months later.

Someone may begin GLP-1 therapy, experience substantial appetite suppression, and lose significant weight without initially noticing anything unusual about their hair.

Then the shedding appears.

That means:

The hair you’re losing today may reflect what was happening in your body months ago.

This is one reason people can believe their medication suddenly started affecting their hair when the process may have begun considerably earlier.

Does Semaglutide Cause Hair Loss?

Hair loss has been reported with semaglutide, and current evidence supports an association between semaglutide treatment and reported hair loss.

Semaglutide is the active ingredient in medications including Ozempic® and Wegovy®.

A 2026 review of 24 studies found semaglutide among the GLP-1 therapies with the strongest hair-loss signals. The review also observed that hair-loss reports appeared more common at higher semaglutide doses used for obesity treatment.

Researchers have not, however, established that semaglutide directly damages the follicle.

Potential contributors include:

  • Rapid weight reduction
  • Reduced food intake
  • Inadequate protein
  • Nutritional deficiencies
  • Physiological stress
  • Telogen effluvium
  • Other metabolic or hormonal changes

This is why determining what type of hair loss is occurring is important.

Does Tirzepatide Cause Hair Loss?

Hair loss has also been reported with tirzepatide, the active ingredient in Mounjaro® and Zepbound®.

Tirzepatide targets both GIP and GLP-1 receptors and can produce substantial weight reduction.

Current research identifies tirzepatide as one of the therapies with a stronger hair-loss signal.

Interestingly, the 2026 systematic review found tirzepatide — which was associated with the greatest magnitude of weight loss among the therapies studied — was also most frequently linked with telogen effluvium.

That provides an important clue.

The magnitude and speed of weight loss may matter.

A person experiencing significant appetite suppression, rapid weight reduction, inadequate protein intake, and reduced overall nutrition could potentially experience several triggers for hair shedding simultaneously.

Does Retatrutide Cause Hair Loss?

There currently isn’t enough evidence to establish that retatrutide directly causes hair loss.

That’s an important distinction from the evidence currently available for semaglutide and tirzepatide.

Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors.

Because clinical research has demonstrated substantial weight reduction with retatrutide, an important research question is whether rapid or substantial weight loss could potentially trigger the same type of telogen effluvium associated with other forms of major weight reduction.

A biologically plausible indirect pathway could look like this:

Appetite reduction

Lower calorie and potentially lower protein/nutrient intake

Rapid or substantial weight loss

Physiological stress

Disruption of the normal hair-growth cycle

Telogen effluvium

Delayed hair shedding

That is a possible mechanism associated with significant weight loss — not proof that retatrutide itself directly causes hair loss.

Research specifically examining retatrutide and hair loss remains limited.

Important Retatrutide Research Note

Retatrutide remains investigational and is not FDA approved. Its safety and effectiveness have not been established by the FDA for any condition.

References to retatrutide in this article concern scientific research only and should not be interpreted as a recommendation for human use.

Is the GLP-1 Causing Hair Loss — or Is It the Weight Loss?

Researchers don’t yet have a definitive answer.

Rapid and substantial weight loss itself is a recognized trigger for telogen effluvium.

This isn’t unique to GLP-1 therapy.

Hair shedding can occur following other situations involving major weight loss, calorie restriction, illness, surgery, or physiological stress.

One possible pathway during GLP-1-assisted weight loss is:

GLP-1 therapy → reduced appetite → reduced calorie/nutrient intake → rapid weight loss → physiological stress → more follicles enter the resting phase → delayed hair shedding

But that pathway may not explain every case.

Researchers continue investigating whether GLP-1 therapies could also affect hair through additional hormonal, metabolic, or follicular mechanisms.

Can Rapid Weight Loss Cause Hair Loss?

Yes. Rapid or substantial weight loss can trigger telogen effluvium.

The body continually allocates energy and nutrients among essential biological processes.

Hair production isn’t required for immediate survival.

During substantial physiological stress or inadequate energy intake, normal hair growth can be disrupted.

This helps explain why hair shedding can occur following:

  • Rapid weight loss
  • Crash dieting
  • Severe calorie restriction
  • Bariatric surgery
  • Serious illness
  • Other significant physiological changes

The goal during weight management therefore shouldn’t simply be to make the scale move as quickly as possible.

Can Not Eating Enough Protein Cause Hair Loss?

Inadequate nutrition can contribute to hair problems, and protein deserves particular attention during significant weight loss.

Hair is composed largely of keratin, a structural protein.

Someone eating substantially less food may unintentionally reduce not only calories but also protein, vitamins, minerals, and essential fats.

This becomes especially relevant when appetite suppression is significant.

The question shouldn’t simply be:

“How little can I eat?”

A better question is:

“Am I still giving my body the nutrition it needs while losing weight?”

Individual protein requirements differ based on body size, age, activity level, health status, and other factors. A healthcare professional or registered dietitian can help establish an appropriate target.

What Nutritional Deficiencies Can Contribute to Hair Loss?

Several nutritional factors may contribute to excessive shedding.

Depending upon someone’s diet, symptoms, and medical history, a healthcare professional may consider evaluating:

Iron and Ferritin

Iron deficiency and depleted iron stores can contribute to hair shedding.

This doesn’t mean everyone experiencing hair loss should automatically take iron.

Unnecessary or excessive iron supplementation can be harmful.

Vitamin D

Vitamin D status may be considered during the evaluation of unexplained hair loss when clinically appropriate.

Zinc

Inadequate zinc can affect normal hair biology.

However, excessive supplementation isn’t necessarily beneficial and can create other nutritional imbalances.

Vitamin B12 and Folate

These nutrients may be considered depending upon diet, medical history, and symptoms.

Overall Calorie Intake

Hair production requires energy.

Prolonged extreme calorie restriction can itself become a physiological stressor capable of affecting the hair-growth cycle.

Does Biotin Help GLP-1 Hair Loss?

Biotin isn’t a universal solution for GLP-1-associated hair loss.

Biotin deficiency can affect hair, but deficiency isn’t responsible for every case of shedding.

Taking increasingly large amounts of biotin won’t necessarily correct hair loss when biotin deficiency isn’t the problem.

Rather than automatically taking multiple supplements, identifying the underlying cause is generally more useful.

How Do You Stop Hair Loss While Taking a GLP-1?

There isn’t one treatment that works for everyone because hair loss can have different causes.

If the underlying problem is telogen effluvium, addressing the trigger becomes particularly important.

1. Evaluate the Rate of Weight Loss

Faster isn’t necessarily better.

Very rapid weight loss can place significant physiological demands on the body.

Someone taking a prescribed GLP-1 who is losing weight extremely rapidly or struggling to consume adequate nutrition should discuss this with the healthcare professional managing treatment.

2. Prioritize Adequate Protein

When appetite decreases, nutrient density becomes increasingly important.

Potential protein sources include:

  • Eggs
  • Fish
  • Poultry
  • Lean meats
  • Greek yogurt
  • Cottage cheese
  • Beans
  • Lentils
  • Soy foods
  • Other appropriate protein sources

There isn’t one protein target appropriate for everyone.

3. Protect Overall Nutrition

Appetite suppression shouldn’t become chronic under-nutrition.

The body still requires adequate:

  • Protein
  • Essential fats
  • Vitamins
  • Minerals
  • Fiber
  • Fluids
  • Energy

4. Investigate Deficiencies Instead of Guessing

Significant or persistent hair loss may warrant professional evaluation.

Depending upon the individual, a clinician may consider:

  • Complete blood count (CBC)
  • Ferritin
  • Iron studies
  • Thyroid function
  • Vitamin D
  • Vitamin B12
  • Folate
  • Zinc when clinically indicated
  • Additional testing based on symptoms and medical history

The goal isn’t to supplement everything associated with hair growth.

The goal is to identify what may actually be wrong.

Can GLP-1 Hair Loss Be Reversed?

When the underlying problem is telogen effluvium, hair growth can generally recover because the follicles haven’t been permanently destroyed.

That’s different from scarring forms of alopecia, where the follicle itself can sustain permanent damage.

Once the underlying trigger resolves, follicles can transition back into their normal growth cycle.

However, correcting the trigger today doesn’t produce full hair density tomorrow.

Hair recovery takes time.

How Long Does GLP-1 Hair Loss Last?

Telogen effluvium often becomes noticeable a few months after its trigger.

Once the trigger is corrected or stabilizes, shedding can improve, but visible recovery takes additional time because newly growing hairs need time to become long enough to noticeably increase density.

For that reason, think in months rather than days or weeks.

Persistent or progressive hair loss should be professionally evaluated rather than indefinitely assuming that a GLP-1 or weight loss is responsible.

Will Hair Grow Back After GLP-1 Hair Loss?

If the shedding represents telogen effluvium, hair regrowth is generally expected once the underlying trigger resolves.

But not every person experiencing hair loss during GLP-1-assisted weight loss necessarily has telogen effluvium.

Some people may have androgenetic alopecia, commonly called male- or female-pattern hair loss.

The two can also occur simultaneously.

A significant episode of diffuse shedding can sometimes reveal genetic thinning that wasn’t previously very noticeable.

This is another reason why determining the type of hair loss matters.

Can Minoxidil Help With GLP-1 Hair Loss?

Minoxidil is an established treatment for certain forms of hair loss and may be appropriate for some people, particularly when androgenetic alopecia is also present.

However, someone experiencing temporary telogen effluvium isn’t necessarily in the same situation as someone experiencing progressive pattern hair loss.

A dermatologist can help identify the type of hair loss and determine whether minoxidil or another treatment is appropriate.

Should You Stop Your GLP-1 Because of Hair Loss?

Don’t discontinue or change the dose of a prescribed GLP-1 solely because of information you’ve read online.

Hair loss has numerous possible causes.

A healthcare professional can evaluate:

  • The pattern and severity of shedding
  • Rate of weight loss
  • Overall calorie and protein intake
  • Nutritional status
  • Thyroid or other medical issues
  • Other medications
  • Family history of hair loss

That information can help determine whether the problem is likely to be temporary telogen effluvium or something requiring different treatment.

When Should Hair Loss Be Evaluated by a Healthcare Professional?

Consider professional or dermatological evaluation if you experience:

  • Distinct bald patches
  • Significant widening of the hair part
  • Progressive thinning at the crown
  • Receding temples or hairline
  • Scalp redness or inflammation
  • Significant itching, burning, pain, or scaling
  • Eyebrow or eyelash loss
  • Extremely rapid or severe shedding
  • Hair loss accompanied by other unexplained symptoms
  • Persistent hair loss after weight and nutrition stabilize

Those findings may indicate something other than temporary telogen effluvium.

GLP-1 Hair Loss FAQ

Does Ozempic cause hair loss?

Hair loss has been reported in people using semaglutide, the active ingredient in Ozempic. Current research supports an association between semaglutide and reported hair loss, but it hasn’t established that semaglutide directly damages hair follicles. Weight loss, nutrition, telogen effluvium, and other factors may contribute.

Does Wegovy cause hair loss?

Hair loss has been reported during semaglutide treatment. Because Wegovy is used for weight management, substantial weight reduction and accompanying nutritional or physiological changes may contribute to shedding in some individuals.

Does Mounjaro cause hair loss?

Tirzepatide, the active ingredient in Mounjaro, has been associated with hair-loss reports. Researchers continue investigating whether this results from medication effects, weight loss, nutritional changes, metabolic factors, or a combination.

Does Zepbound cause hair loss?

Hair loss has been reported during tirzepatide treatment. Current evidence supports an association, while substantial weight reduction and telogen effluvium may contribute.

Does semaglutide hair loss grow back?

When shedding is caused by telogen effluvium, follicles generally remain intact and capable of producing new hair after the underlying trigger resolves.

Does tirzepatide hair loss grow back?

The answer depends on the cause. If tirzepatide-associated shedding represents telogen effluvium triggered by rapid weight loss or related physiological changes, hair growth can generally recover after the trigger stabilizes.

Does retatrutide cause hair loss?

There isn’t currently enough evidence to establish that retatrutide directly causes hair loss. However, substantial weight loss itself can potentially trigger telogen effluvium. Retatrutide remains investigational, and additional clinical research is needed.

Is retatrutide a GLP-1?

Retatrutide is more accurately described as an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors.

Is retatrutide FDA approved?

No. Retatrutide remains investigational and is not currently an FDA-approved medication.

How soon after starting a GLP-1 can hair loss occur?

Telogen effluvium commonly becomes noticeable weeks to months after the physiological event that triggered the change in the hair cycle. This delay means shedding may not become obvious until well after significant weight loss begins.

Does protein help prevent GLP-1 hair loss?

Adequate protein is important for normal body function and hair production, particularly when total food intake decreases substantially. However, protein alone can’t prevent every form of hair loss.

What is the best vitamin for GLP-1 hair loss?

There isn’t one vitamin proven to correct every case of GLP-1-associated hair loss. If a nutritional deficiency is contributing, correcting that specific deficiency may help. Testing and appropriate evaluation are preferable to indiscriminate high-dose supplementation.

Does biotin help GLP-1 hair loss?

Biotin may help when someone is actually biotin deficient, but there isn’t evidence that high-dose biotin universally treats GLP-1-associated hair shedding.

Is GLP-1 hair loss permanent?

Telogen effluvium is generally a non-scarring and reversible form of hair loss. Other types of hair loss can behave differently, so persistent or patterned thinning should be professionally evaluated.

How do you reverse GLP-1 hair loss?

There isn’t a universal reversal treatment. When telogen effluvium is responsible, identifying and addressing the trigger — such as rapid weight loss, inadequate nutrition, or a deficiency — can allow the normal hair-growth cycle to recover. Other forms of hair loss may require different treatment.

The Bottom Line: GLP-1 Hair Loss Is More Complicated Than It Sounds

Current research supports an association between GLP-1 therapies and hair loss, with particularly notable evidence involving semaglutide and tirzepatide.

But the science doesn’t support reducing the issue to:

“GLP-1s make your hair fall out.”

Several factors may be involved:

Rapid weight loss + reduced calorie intake + inadequate protein + nutritional deficiencies + physiological stress + metabolic changes + underlying genetic hair loss.

Research specifically connecting retatrutide to hair loss remains limited, so claims that retatrutide directly causes hair loss would be premature.

When the underlying condition is telogen effluvium, however, there’s an important distinction:

The follicle generally hasn’t been permanently destroyed.

Instead of immediately asking:

“What hair supplement should I take?”

Start with:

“Why is my hair falling out?”

Identify the type of hair loss.

Evaluate the speed of weight loss.

Protect adequate protein and overall nutrition.

Identify genuine deficiencies rather than guessing.

Seek professional evaluation when the shedding is severe, persistent, patterned, or otherwise concerning.

And remember that hair follicles need time to return to their normal growth cycle.

Successful weight management isn’t simply about how quickly the number on the scale changes. Supporting the body throughout that process matters too.

About Mile High Peptides

Mile High Peptides LLC provides educational resources designed to make emerging peptide and metabolic research easier to understand.

Explore the Mile High Peptides Education Hub for additional research-focused articles and educational resources.

References & Further Reading

Gupta AK, Teasell EM, Economopoulos V, Mirmirani P. GLP-1 Therapies and Hair Loss: A Systematic Review of Current Evidence and Implications for Counseling. Science Progress. 2026.

Cheng PL, Chang HC. Glucagon-like Peptide-1 Receptor Agonists and Hair Loss: A Systematic Review and Meta-analysis. Diabetes Research and Clinical Practice. 2026;237:113333.

Branyiczky MK, Lowe MS, McMullen E, Donovan J, Khosravi-Hafshejani T. Effects of GLP-1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review. International Journal of Dermatology. 2026.

Healthline. GLP-1 Drugs Like Ozempic May Cause Hair Loss, Researchers Say. How to Treat It. Updated 2026.

U.S. Food and Drug Administration. Information concerning unapproved GLP-1 drugs and investigational retatrutide.

Educational & Research Disclaimer

This content is provided by Mile High Peptides LLC for educational and informational purposes only and does not constitute medical advice, diagnosis, treatment recommendations, or instructions for the use of any medication or research compound.

Prescription medications should be used only under the supervision of an appropriately licensed healthcare professional. Do not start, discontinue, change the dosage of, or otherwise modify a prescribed medication based on information contained in this article.

Retatrutide is investigational and is not currently FDA approved. References to retatrutide in this article concern scientific research and are not intended to recommend or promote human use.

Individuals experiencing significant, persistent, sudden, patterned, or otherwise concerning hair loss should consult an appropriately qualified healthcare professional.

© 2026 Mile High Peptides LLC

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *